<?xml version="1.0" encoding="UTF-8"?>
<ref id="B257-vaccines-08-00036">
 <label>257.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Billerbeck</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Barry</surname>
    <given-names>W.T.</given-names>
   </name>
   <name>
    <surname>Mu</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Dorner</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Rice</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Ploss</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rgamma(null) humanized mice</article-title>
  <source>Blood</source>
  <year>2011</year>
  <volume>117</volume>
  <fpage>3076</fpage>
  <lpage>3086</lpage>
  <pub-id pub-id-type="doi">10.1182/blood-2010-08-301507</pub-id>
  <?supplied-pmid 21252091?>
  <pub-id pub-id-type="pmid">21252091</pub-id>
 </element-citation>
</ref>
